Sorry, you need to enable JavaScript to visit this website.
Home About Responsibility Global Impact Response to Ukraine

How Pfizer is Responding to the Crisis in Ukraine

Deeply concerned by the human suffering we all are witnessing during the ongoing crisis in Ukraine, Pfizer is committed to contributing to ongoing humanitarian efforts that support the safety, health and wellbeing of people affected by these tragic events.

Consistent with our company values, Pfizer is determined to ensure the safety of our colleagues and their families. We are equally determined to facilitate continued access to our medicines and vaccines for patients.

Bearing in mind the exception of medicines from the international community’s sanctions on Russia, Pfizer has concluded that a voluntary pause in the flow of our medicines to Russia, including cancer and cardiovascular therapies, would cause significant suffering and potential loss of life, particularly among children and older people. Pfizer will donate all profits of our Russian subsidiary to causes that provide direct humanitarian support to the people of Ukraine.


We hope for peace. Until then, we will continue to work with partners to evaluate the evolving needs of our colleagues and patients so that we can fulfil our purpose and respond to those in need. 

See our latest statement on Russia here

Our current efforts include:

  • Pfizer has a cross-functional team of people dedicated to ensuring the safety of our colleagues and contractors based in Ukraine. We remain in close contact during this extremely challenging time, and we continue to provide advice and support. 

    We’re also helping to ensure the well-being of our colleagues in Russia too, who continue to work to serve patients in accordance with the international sanctions applicable to the provision of healthcare.

  • We are working hard to facilitate patients’ access to the medicines and vaccines they need. We have established robust and preventative measures as well as flexible routes to help minimize impact on supply.

    We continue to manage stock levels of critical medicines and vaccines in both Ukraine and Russia.  

    We are also making a strong effort to facilitate continued provision of our life-saving medicines to patients impacted by sanctions. Pfizer maintains a robust restricted party screening program to confirm compliance with sanctions and other applicable laws in the markets in which we operate. 

    We are collaborating with our research partners in the region to mitigate impact to our clinical programs. In the interests of patient safety, we have made theecessary decision to pause the recruitment of new participants to clinical trial programs, and we will do all we can to maintain continuity of care for patients actively participating in trials. We will continue to evaluate the situation and adjust our approach, as needed.

  • To date, we have activated a number of humanitarian efforts.

    • Through The Pfizer Foundation*, we have provided US $2 million in humanitarian grant funding to the following organizations working in Ukraine and surrounding countries:
      • American Red Cross to support emergency teams in Ukraine and surrounding countries who are working to repair vital infrastructure, support health facilities with medicines and equipment, and support families with food and hygiene resources. Funds donated through the American Red Cross will support the Ukrainian Red Cross response, as well as regional Red Cross efforts in surrounding countries to support immediate needs of affected populations.
      • International Medical Corps (IMC)  to support essential emergency and primary health services, mental health and psychosocial support services, and protection and gender-based violence services, which are critical for conflict-affected communities. COVID-19 awareness and prevention services will be incorporated into these efforts to help keep displaced people safe from the pandemic.
      • International Rescue Committee (IRC)  to support their efforts in bordering countries to mobilize resources and connect with partners to help provide life-saving support to people forced to flee their homes.
      • The UN Refugee Agency (UNHCR)  to support emergency relief priorities in Ukraine and immediate needs of displaced populations in surrounding countries now hosting Ukraine refugees. UNHCR is the leading UN agency coordinating all inter-agency regional efforts across UN agencies, NGOs and other relevant partners to maximize and effectively coordinate refugee response efforts.
    • We have launched the Ukraine Humanitarian Disaster Campaign to provide all eligible colleagues the opportunity to donate to key organizations helping those impacted by the conflict in Ukraine and neighboring countries. The Pfizer Foundation* is matching colleague financial donations made through this campaign to organizations including UNICEF, the International Rescue Committee, Save the Children, the American Red Cross, CARE, Nova Ukraine and Sunflower of Peace. 
      • As of March 11, 2022, thousands of colleagues from nearly 54 countries have donated nearly US $621,000.
      • Including The Pfizer Foundation’s dollar-for-dollar match, the total donation is approaching US $1.25million
    • We have received detailed requests from the Ukrainian Ministry of Health through our NGO partners for medicines and vaccines and have responded with donations both from our existing supply in Ukraine and from the U.S. These donations — which include nearly 700,000 doses of lifesaving antibiotics, antifibrinolytics, and oncology medicines — are intended to help healthcare providers and relief workers treat patients in Ukraine and neighbouring countries.

    *The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.